IHCAN Conferences Virtual Event

Featuring an all star IHCAN Conference line-up: Alessio Fasano M.D, Tom O'Bryan, DC, CCN, DACBN and Katie Sheen FdSc, DipION, PGCE, MA (Education)

Saturday 14 November 2020 (09.45 – 17.15)

Buy the downloads

Although live education is “paused” for 2020, we have doubled our efforts on organising online education so you can keep up-to-date during these challenging times.

We know you’ve missed our one-day conferences and you’re ready for something more in-depth than a quick one-hour webinar. That’s why we’re delighted to announce a full day of education in typical IHCAN Conference style – but virtual.

We’ve got world-class speakers and, thanks to a bespoke bit of techno-wizardry, you’ll enjoy a virtual expo featuring specialist practitioner suppliers as well as short break-out sessions and online networking.

For the full schedule, see below, or click here to download a PDF.

 

How is it different to the IHCAN Conference Webinars?
 

Using a brand new, bespoke, virtual conference and expo platform, the IHCAN Conferences Virtual Event is a whole-day event with multiple live sessions and a virtual exhibition – bringing the “in-person” conference experience direct to your device.

How does it work?

 

We’re using a bespoke virtual conference and expo platform – you don’t need to  download any additional software and it will work on every device.

It works best on Google Chrome or Mozilla Firefox and we recommend you make sure your browser is up-to-date.

We’ll send you access details two weeks before the event.

What exhibitors will be featured?

 

Demand for “stands” is high and we’re adding new companies as fast as we can organise virtual space, so keep checking back, but some of the suppliers confirmed so far include:

Bio-Kult – Diamond Sponsor
BioMedica – Gold sponsor
Pure Encapsulations – Gold Sponsor
Aura & Meta
Ki Science
Solgar
IHCAN magazine
Institute for Optimum Nutrition
The Nutrition Network

They’re all showcasing their new products, latest research and show-only offers.

Featuring:

ALESSIO FASANO, M.D.
Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children – Harvard Medical School, Boston, MA – U.S.A. And European Biomedical Research Institute Salerno (EBRIS) Salerno – Italy

TOM O’BRYAN, DC, CCN, DACBN

Tom O’Bryan is a world-renowned expert in the field of gluten-related disorders, Non-Celiac Gluten Sensitivity (NCGS), Celiac Disease (CD) and their link to other chronic conditions, including autoimmune disorders and diseases.

KATIE SHEEN FdSc, DipION, PGCE, MA (Education).
Originally teaching nutrition on Masters Degree and Diploma courses for University and College students, she was gradually invited to share her practice of mindfulness at the workplaces of some of the post-graduate students that she had the pleasure of working with.

9.45 – 10.00 

Introduction/set the scene

 

10.00 – 11.00

‘How can Mindfulness enhance Self-Care?’
Katie Sheen FdSc, DipION, PGCE, MA (Education)

Mindful self-care begins with yourself, but is ultimately for the benefit of everyone around you and is a very un-selfish act.
Once you have learned how to take care of yourself, then you can turn outwards again. As your personal sense of security increases, it becomes easier to be more outward looking, more inclusive, and more effective with clients.

To have the confidence to stop running through life, to know how to come back to yourself and re-set your nervous system to a baseline from where you can see things more clearly, think more creatively and act more effectively is a self-care skill for the whole of life, both personal and professional.

Mindful breathing becomes incredibly effective at building up a sense of safety and security deep in the centre of your body that you can tap into at any time, enabling you to walk steadily through the eye of a storm of situations and emotions. The calm, focused awareness that accompanies this sense of inner strength helps you to assess things more objectively as they happen, responding with clarity and creativity in order to take effective action that can transform a situation.

About Katie Sheen FdSc, DipION, PGCE, MA (Education)

 

Katie Sheen FdSc, DipION, PGCE, MA (Education) holds a Masters Degree in Education, a Post Graduate Certificate in Learning and Teaching in Higher Education, and is a Fellow of The Higher Education Academy. Originally teaching nutrition on Masters Degree and Diploma courses for University and College students, she was gradually invited to share her practice of mindfulness at the workplaces of some of the post-graduate students that she had the pleasure of working with.

Through an expanding network of personal recommendations she has now led bespoke workshops and webinars for corporate clients including Adidas, Barclays, Barclaycard, Deloitte, Equity Housing Group, Greater Manchester Police and Sellafield, as well as charities and support groups including Brain Tumour Support, Heart Valve Voice and the COVID-19 Primary Care web meet for UK Healthcare Professionals.

She has presented at conferences to a wide range of audiences, from the Northern Counties Society of Osteopaths to the Master Innholders General Managers, contributed interviews and articles to magazines and websites, and made guest appearances on podcasts and live radio.

11.00 – 12.00

Assorted Breakout Sessions

A selection of four smaller breakout sessions – in a traditional webinar style – on a variety of topics. Take your pick! Don’t worry if you want to attend more than one – we’ll send you the recordings from every session after the event.

The Microbiome as an Endocrine Organ, hosted by Bio-Kult

 

The gut microbiome contributes to the regulation of many aspects of endocrine function, leading some researchers to view the microbiome as a ‘virtual’ endocrine organ in its own right. This webinar will focus on how the gut microbiome influences the host endocrine system, specifically in terms of the oestrobolome and thyroid health and what evidence there is for modulating the gut microbiome in both oestrogen-dependent conditions and thyroid disorders.

About the presenter

Hannah Braye is a registered Nutritional Therapist, graduating from the College of Naturopathic Medicine (CNM) with an award for outstanding performance. She is accredited by the British Association of Nutrition and Lifestyle Medicine and the Complementary and Natural Healthcare Council and is currently enrolled on an MSc in Personalised Nutrition accredited by the University of Middlesex. She has been at ADM Protexin since 2017. As Senior Technical Advisor she manages the in-house human healthcare Technical Team.

What is your immune age? Holistic interventions for healthy immune aging, hosted by BioMedica

 

It is now recognised that the elderly, those with comorbidities and the immunosuppressed are more vulnerable to infectious and chronic diseases.  This vulnerability arises from the gradual age-related deterioration of the immune system, referred to as immunosenescence, and concomitant increases in low-grade systemic inflammation, termed inflammaging. However, aging does not affect all immune systems equally, and the rate of decline in the immune system can be accelerated by multiple environmental and lifestyle factors such as a sedentary lifestyle, smoking, stress, medications, health behaviours and nutritional status. Coupled with genetic background, these environmental and lifestyle factors can determine an individual’s ‘immune age’; which is being explored by researchers to explain immune variation in adults. An individual’s immune age can vary from their chronological age and may explain why individuals have increased vulnerability to infection and disease. Thus diet and lifestyle interventions can be an effective approach to improving immune outcomes in adulthood and supporting healthy aging.

About the presenter

Daniel Baden is a well-known and respected Naturopath and Homoeopath within the Australian and international complementary therapies industry and community. Beginning his journey as a clinician, Daniel has assumed many roles over the years including; consultant to and member of industry regulatory committees, providing technical support to practitioners, assisting various groups in research projects, lecturer, author and co-founder of BioMedica Nutraceuticals . He is currently on the executive board of Complementary Medicines Australia (CMA) as chair of the practitioner committee. A highly experienced presenter, Daniel has been lecturing to the general public, undergraduates and practitioners since 1990. His extensive experience and interest in ongoing practitioner education, ensures his seminars are an empowering and worthwhile experience for all attendees.

GI Biomarkers: Navigating Gastrointestinal Assessment and Function, hosted by Pure Encapsulations

 

Functional gastrointestinal disorders – such as irritable bowel syndrome (IBS), functional dyspepsia, bloating, constipation and diarrhoea – are due to many different possible causes unique to each individual. The identification of various causes of gastrointestinal symptoms can be made possible with laboratory and clinical biomarkers, some of which are actionable and can be used to guide personalised nutrition and lifestyle medicine.

However, not all biomarkers are valid, reliable or cost effective. This important seminar critically reviews the clinical usefulness of available biomarkers that measure changes in the microbiome, gastrointestinal function, intestinal permeability, immune activation, food intolerances, nutritional status and genetics.

Actionable biomarkers have the potential to replace non-specific, symptom-based treatments by identifying the underlying reason for symptoms and revealing which people are most likely to respond to specific therapies.

Key topics;
• Critically review assessments of gastrointestinal function and their clinical usefulness.
• Cover physiological, stool, mucosal, microbial, blood and genetic biomarkers.
• Learn how biomarkers could replace symptom-based criteria and identify subgroups of patients according to disease mechanisms.
• Explore how to personalise nutritional therapy for gastrointestinal health.
• Receive an evidence-based clinical reference that helps navigate biomarkers and their interpretation.

About the presenter

Benjamin I. Brown, ND is a science writer and speaker specializing in nutrition and functional medicine. He an author and contributes regularly to industry magazines and scientific journals. Ben is founder and director of the Nutritional Medicine Institute, contributing editor of Integrative Healthcare and Applied Nutrition, consultant and director of clinical education for Pure Encapsulations UK and Ireland, and on the advisory board and lecturer at BCNH College of Nutrition and Health. Ben guest lectures at the Institute of Optimum Nutrition (ION) and the Centre for Nutrition Education & Lifestyle Management (CNELM). He hosts Positive Health Podcast. Learn more at scientificwellness.com.

Autonomic Response Testing A.R.T. ®: the most reliable diagnostic technique, hosted by Dr Dietrich Klinghardt

 

Developed by Dr Klinghardt, Autonomic Response Testing A.R.T.® is a simple yet highly effective biofeedback assessment technique that uses an advanced form of muscle testing to measure the autonomic nervous system.

A.R.T. is used to determine disturbances in your body, possible remedies, and also to prioritise effective treatments.
A.R.T. is non-invasive, non-electronic, and can be used to assess people of any age to find the root causes of illness, dysfunction and blockages.

The success of his approach has earned Dr Klinghardt worldwide recognition for his trailblazing work with people suffering from chronic illnesses, including Lyme and Autism.

Key topics:

  • The relevance of this refined system of interpreting muscle response
  • What differentiates A.R.T. from other forms of muscle testing?
  • What can A.R.T. be used for?
  • Why A.R.T. is a reliable tool for detecting tissue dysfunction and establishing an accurate diagnosis
  • How A.R.T. can achieve diagnostics that cannot currently be performed with conventional medical lab work.
  • How A.R.T. enables practitioners to receive a clear indication and clinical reference that helps to navigate the true causes of chronic illness
  • Why this method has become so phenomenal in its accuracy
  • How A.R.T. is a fantastic tool for defining treatment options
  • How A.R.T. is designed to give reliable and reproducible results.

Full details to be confirmed shortly.

About the presenter

Dr Klinghardt MD, PhD is an internationally renowned neurobiologist, recognised for his successful treatment of chronic pain, Lyme disease & Autism. His treatments combine non-surgical orthopaedic medicine with immunology, endocrinology, toxicology and neural therapy, in accordance with the 5 Levels of Healing™. Dr Klinghardt MD, PhD, is Founder of the Klinghardt Institute (UK) www.klinghardtinstitute.com and Klinghardt Education (UK), the American Association of Neural Therapy, and is lead clinician at the Sophia Health Institute located in Woodinville, Washington. He is also Founder and Chairman of the Institute for Neurobiology (Germany).

Dr Klinghardt has lectured at the universities of Illinois, Utah, Freiburg, Adelaide, Capital University (Washington DC), and the medical schools of Geneva and Zurich. Between 1996-2005 he was Associate Professor at the Department of Applied Neurobiology at Capital University. He is regularly invited to teach workshops at the prestigious Medicine Week in Baden-Baden, Germany and the International Lyme and Associated Diseases (ILADS) conferences. Among his books is the groundbreaking Psychokinesiology: A new Approach in Psychosomatic Medicine, on muscle feedback-guided psychotherapy.

12.00 – 13.00

Break/Exhibition

Take some time away from your screen or browse our virtual exhibition booths.

13.00 – 14.00

‘The Healing Power Of Nutrition: How Diet Can Reshape Gut Microbiome And Influence The Balance Between Health And Disease’ Part one
Alessio Fasano, M.D.

Improved hygiene leading to a reduced exposure to microorganisms has been implicated as one possible cause for the recent ‘epidemic’ of chronic inflammatory diseases (CID) and autoimmunity in industrialised countries.

This “hygiene hypothesis” argues that rising incidence of CID may be, in part, the result of lifestyle and environmental changes that have made us too “clean” for our own good. Along with genetic make-up and exposure to environmental triggers, three more elements have been recently identified as key players.

One is the inappropriate increase in intestinal permeability, which may be influenced by the composition of the gut microbiota. The immune system, responsible for the tolerance-immune response, represents the fourth element.

Finally, the composition of the gut microbiome and its epigenetic influence on host genomic expression is a fifth element . The gut microbiome consists of more than 100 trillion microorganisms, most of which are bacteria. It has been just recently recognised that there is a close bidirectional interaction between the microbiome and our immune system, and this cross-talk is highly influential in shaping the host gut immune system function and, ultimately, shifting genetic predisposition to clinical outcomes.

This observation led to researchers revisiting the possible causes of CID epidemics, suggesting a key pathogenic role for microbiome composition. While factors such as modality of delivery, neonatal feeding regimens, use of antibiotics and infections can influence microbiota composition, diet is by far the most important variable affecting the gut ecosystem. Therefore, re-shaping gut microbiota through dietary manipulation is becoming an extremely active area of research for the prevention or treatment of a multitude of chronic inflammatory diseases.

About Alessio Fasano, M.D.

 

Alessio Fasano, MD, is the W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition and Chief of the Division of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children (MGHfC). His visionary research, which established the rate of celiac disease at one in 133 people, led to the awareness of celiac disease as a growing public health problem in the United States. Dr. Fasano founded the Center for Celiac Research and Treatment in 1996, where he treats adults and children for gluten-related disorders.

Dr. Fasano is also Director of the Mucosal Immunology and Biology Research Center (MIBRC) at MGHfC. In 2000, he and his team discovered the protein zonulin, opening up the door to a new way of looking at the function of intestinal permeability, not only as it affects the gut, but also what role it plays in both inflammation and autoimmunity throughout the body. Current research directed by Dr. Fasano encompasses both basic science focused on bacterial pathogenesis, the gut microbiome and intestinal mucosal biology, as well as translational science focused on interventional clinical trials in autoimmune and inflammatory diseases.

Led by Dr. Fasano, MIBRC researchers are looking at how qualitative or quantitative defects in the regulation of the immune system and the role of dysbiosis can lead to the onset and progression of celiac disease and other autoimmune disorders. Dr. Fasano’s objective is to understand the molecular mechanisms of the host’s functional and immune response to specific organisms and develop preventive strategies for autoimmune disorders.

A passionate advocate for collaboration in research and clinical work, Dr. Fasano recently authored Gluten Freedom to provide patients, healthcare providers and general readers an evidence-based yet entertaining book to dispel confusion about gluten and how it can affect your health. Dr. Fasano is widely sought after as an expert in celiac disease, intestinal permeability and autoimmune disorders and has been featured in media outlets around the world, including National Public Radio, The Wall Street Journal, The New York Times, The Washington Post, The Daily Mail, Elle, TIME and other online and media outlets.

14.00 – 14.30

Break/Exhibition

Take some time away from your screen or browse our virtual exhibition booths.

14.30 – 15.30

‘The Healing Power Of Nutrition: How Diet Can Reshape Gut Microbiome And Influence The Balance Between Health And Disease’ Part two
Alessio Fasano, M.D.

Improved hygiene leading to a reduced exposure to microorganisms has been implicated as one possible cause for the recent ‘epidemic’ of chronic inflammatory diseases (CID) and autoimmunity in industrialised countries.

This “hygiene hypothesis” argues that rising incidence of CID may be, in part, the result of lifestyle and environmental changes that have made us too “clean” for our own good. Along with genetic make-up and exposure to environmental triggers, three more elements have been recently identified as key players.

One is the inappropriate increase in intestinal permeability, which may be influenced by the composition of the gut microbiota. The immune system, responsible for the tolerance-immune response, represents the fourth element.

Finally, the composition of the gut microbiome and its epigenetic influence on host genomic expression is a fifth element . The gut microbiome consists of more than 100 trillion microorganisms, most of which are bacteria. It has been just recently recognised that there is a close bidirectional interaction between the microbiome and our immune system, and this cross-talk is highly influential in shaping the host gut immune system function and, ultimately, shifting genetic predisposition to clinical outcomes.

This observation led to researchers revisiting the possible causes of CID epidemics, suggesting a key pathogenic role for microbiome composition. While factors such as modality of delivery, neonatal feeding regimens, use of antibiotics and infections can influence microbiota composition, diet is by far the most important variable affecting the gut ecosystem. Therefore, re-shaping gut microbiota through dietary manipulation is becoming an extremely active area of research for the prevention or treatment of a multitude of chronic inflammatory diseases.

About Alessio Fasano, MD.

 

Alessio Fasano, MD, is the W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition and Chief of the Division of Pediatric Gastroenterology and Nutrition at MassGeneral Hospital for Children (MGHfC). His visionary research, which established the rate of celiac disease at one in 133 people, led to the awareness of celiac disease as a growing public health problem in the United States. Dr. Fasano founded the Center for Celiac Research and Treatment in 1996, where he treats adults and children for gluten-related disorders.

Dr. Fasano is also Director of the Mucosal Immunology and Biology Research Center (MIBRC) at MGHfC. In 2000, he and his team discovered the protein zonulin, opening up the door to a new way of looking at the function of intestinal permeability, not only as it affects the gut, but also what role it plays in both inflammation and autoimmunity throughout the body. Current research directed by Dr. Fasano encompasses both basic science focused on bacterial pathogenesis, the gut microbiome and intestinal mucosal biology, as well as translational science focused on interventional clinical trials in autoimmune and inflammatory diseases.

Led by Dr. Fasano, MIBRC researchers are looking at how qualitative or quantitative defects in the regulation of the immune system and the role of dysbiosis can lead to the onset and progression of celiac disease and other autoimmune disorders. Dr. Fasano’s objective is to understand the molecular mechanisms of the host’s functional and immune response to specific organisms and develop preventive strategies for autoimmune disorders.

A passionate advocate for collaboration in research and clinical work, Dr. Fasano recently authored Gluten Freedom to provide patients, healthcare providers and general readers an evidence-based yet entertaining book to dispel confusion about gluten and how it can affect your health. Dr. Fasano is widely sought after as an expert in celiac disease, intestinal permeability and autoimmune disorders and has been featured in media outlets around the world, including National Public Radio, The Wall Street Journal, The New York Times, The Washington Post, The Daily Mail, Elle, TIME and other online and media outlets.

15.30 – 16.00

Break/Exhibition

Take some time away from your screen or browse our virtual exhibition booths.

16.00 – 17.00

‘The Canary’s Song’
Tom O’Bryan, DC, CCN, DACBN

Why are we surprised when we get a diagnosis of a chronic inflammatory disease (CID)? As Holistic Health Practitioners, with all of the knowledge we have today, what are we missing? How is it that we’re startled by such a diagnosis? With a 200% overall increase in dementia in the 30-64 year olds in the last 4 years (373% ages 30-44, 311% ages 45-54, 143% ages 55-64), something is seriously being missed. For example, when you test for a wheat sensitivity by testing gluten, and it comes back negative, is it ok to eat wheat? Of course not. Wheat amylase-trypsin inhibitors only make up 4% of wheat proteins, but they are highly sensitive activators of barrier dysfunction (gut and brain), and major activators of systemic immune response, including the brain. Thus, testing exclusively for gluten sensitivity is limited in scope.

The sweetness of a canary’s song brings a sense of calm and serenity. Yet, that same sweet sound, or lack thereof, can be a harbinger of grave danger. The brain has been referred to as the ‘Canary in the Coal Mine’ of chronic inflammatory diseases.

What is the pathway from noxious environmental triggers to chronic inflammatory brain diseases (CIDs)? How do we go from health to dementia, Alzheimer’s, Parkinson’s,… ? As we are learning more about the critically important role of the microbiome in the development of chronic inflammatory diseases (CIDs), the mechanisms by which these downstream effects occur is becoming more widely understood. Too often our protocols bring partial, but not total gut restoration. What are we missing?

Having an expanded recognition of the steps in the transition from environmental triggers through dysbiosis to biomarkers of brain inflammation allows the Clinician more therapeutic tools, addressing more of the stages of development, eventually increasing the arrest of the downstream inflammatory cascade.

About Tom O'Bryan, DC, CCN, DACBN

 

Tom O’Bryan is a world expert on gluten and it’s impact on your health. He is an internationally recognised and sought after speaker and workshop leader specialising in the complications of Non-Coeliac Gluten Sensitivity, Coeliac Disease, and the development of Autoimmune Diseases as they occur inside and outside of the intestines. He is the founder of www.theDr.com and the visionary behind ‘The Gluten Summit – A Grain of Truth’, bringing together 29 of the world’s experts on the Gluten connection to diseases, disorders, and a wide-range of symptoms and ages. You can find this info at www.theglutensummit.com.

Tom O’Bryan is considered the ‘Sherlock Holmes’ for chronic disease and metabolic disorders. He is a clinician par excellence in treating chronic disease and metabolic disorders from a Functional Medicine Perspective. He holds adjunct Faculty positions with the Institute for Functional Medicine and the National University of Health Sciences. He has trained thousands of practitioners around the world in advanced understanding of the impact of food related disorders and the development of individual autoimmune diseases.

17.00 – 17.15 

Final thoughts

We have applied for CPD accreditation from:

     

Proudly sponsored by

Platinum Sponsor

Diamond Sponsor

Gold Sponsor

Gold Sponsor

To buy the downloads from the first virtual IHCAN Conference (featuring Dr Samuel Yanuck, Dr Dale Bredesen
and Alex Manos) which took place on 12 September 2020, click here

Book your place